Published

Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Expert opinion on drug discovery
Date: 2022-10-01
Source: PubMed
DOI: 10.1080/17460441.2022.2111415
PubMed: 35934973

Authors

Pilc A Machaczka A Kawalec P Smith JL Witkin JM

Watch author

Derived topics and classifications

psilocybin Depression Pharmacology Mechanism of Action Receptor Pharmacology Animal Study Animal Study

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.2022-10-01

Related papers

Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?UKnowledge (University of Kentucky) · 2025-03-04 Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Hallucinogens induce a specific barcode of phosphorylation on the serotonin2A receptor that underlies a weaker receptor desensitization and internalizationReceptors & Clinical Investigation · 2014-09-27